Buana Finance Tbk vs Kimia Farma Tbk — how do they compare? Buana Finance Tbk trades at Rp535 (market cap 880.5B, 78.7K 24h volume), while Kimia Farma Tbk trades at Rp452 (market cap 2.53T, 344.5K 24h volume). The key difference: Kimia Farma Tbk is far larger — about 2.9× Buana Finance Tbk's market cap, and Kimia Farma Tbk is more actively traded (344.5K versus 78.7K). Which is the better fit depends on your goals.
| BBLD | KAEF | |
|---|---|---|
Market Cap | 880.5B | 2.53T |
Volume | 78.7K | 344.5K |
Lot | 787 | 3.45K |
Turnover | 42.09M | 156.07M |
Average Price | 534.78 | 453.03 |
Value | 42.09M | 156.07M |
Indicative Equilibrium Price | 540 | 452 |
Indicative Equilibrium Volume | 2 | 4 |
Trailing returns across standard periods
Latest headlines on both assets
PT Buana Finance Tbk (the Company) formerly PT. BBL Dharmala Finance Tbk was incorporated on June 7, 1982 as a leasing company with a joint venture between PT. Dharmala Sakti Sejahtera Tbk of Indonesia and Bangkok Bank Pcl of Thailand. At January 05, 2006 company's name was changed to PT Buana Finance Tbk.
Read more on BBLD →PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Read more on KAEF →